- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Sphincter of Oddi.
Displaying page 1 of 1.
EudraCT Number: 2018-004239-63 | Sponsor Protocol Number: NL68231.078.18 | Start Date*: 2019-08-23 | |||||||||||
Sponsor Name:Erasmus MC | |||||||||||||
Full Title: Botulinum toxin (BOTOX®) to prevent post-operative pancreatic fistula in patients who undergo distal pancreatectomy. PROFIT study. | |||||||||||||
Medical condition: Post-operative pancreatic fistula | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-006001-35 | Sponsor Protocol Number: PREBOT-II | Start Date*: 2021-10-27 | |||||||||||
Sponsor Name:University Hospital Heidelberg | |||||||||||||
Full Title: Randomized controlled trial of PREoperative injection of BOTulinum toxin into the sphincter of Oddi to reduce bile leakage after hepatic resection PREBOT-II | |||||||||||||
Medical condition: Patients undergoing partial hepatic resection for various underlying diseases. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002461-35 | Sponsor Protocol Number: PREBOTPilot | Start Date*: 2019-12-06 | |||||||||||
Sponsor Name:Ruprecht-Karls-University Heidelberg Medical Faculty represented by Universitätsklinikum Heidelberg and its acting Comm | |||||||||||||
Full Title: Monocenter, randomized, controlled, open-label, phase-II clinical trial of PREoperative endoscopic injection of BOTulinum toxin in the sphincter of Oddi to reduce postoperative pancreatic fistula a... | |||||||||||||
Medical condition: Elective distal pancreatectomy for any underlying disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005216-15 | Sponsor Protocol Number: ABO-NB-15 | Start Date*: 2016-07-06 | |||||||||||||||||||||
Sponsor Name:ABOCA S.P.A. SOCIETà AGRICOLA | |||||||||||||||||||||||
Full Title: Relief of heartburn and epigastric pain comparing Neobianacid® with omeprazole: a randomized, double blind, double dummy, reference product controlled, parallel group, non-inferiority clinical study | |||||||||||||||||||||||
Medical condition: GERD (Gastroesophageal Reflux Disease) and/or EPS (Epigastric Pain Syndrome) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
